A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal Carcinomatosis

NCT04047771 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped terminated

Conditions

Peritoneal Carcinomatosis

Interventions

DRUG: SCB-313

Sponsor

Sichuan Clover Biopharmaceuticals, Inc.